Table 1.
Patient characteristics
| Cirrhosis, no infection (n = 39) | Cirrhosis, infection (n = 45) | P-value | |
|---|---|---|---|
| Years of age, median (range) | 58 (37–82) | 58 (40–80) | 0·437 |
| Male sex, no. (%) | 32 (82) | 33 (73) | 0·341 |
| Aetiology, no. (%) | 0·953 | ||
| Alcohol | 31 (79) | 36 (80) | |
| Virus | 2 (5) | 2 (4) | |
| Cryptogen | 3 (8) | 3 (7) | |
| Other | 3 (8) | 4 (9) | |
| Child–Pugh stage, no. (%) | 0·147 | ||
| A | 5 (13) | 2 (4) | |
| B | 22 (56) | 21 (47) | |
| C | 12 (31) | 22 (49) | 0·092 |
| MELD score, median (range) | 13·5 (8–28) | 15 (7–40) | 0·057 |
| Presence of ascites, no. (%) | 28 (72) | 39 (87) | 0·091 |
| Laboratory values, median (range) | |||
| Bilirubin, µmol/l | 43 (9–504) | 38 (5–531) | 0·920 |
| INR | 1.4 (0·9–2·4) | 1·4 (1·0–2·2) | 0·594 |
| Creatinine, µmol/l | 81 (43–171) | 97 (40–351) | 0·083 |
| ALT, µmol/l × s | 0·65 (0·31–3·63) | 0·60 (0·14–1·46) | 0·238 |
| Leucocyte count, Gpt/l | 5·6 (2·4–10·7) | 7·8 (2·7–32·3) | <0·001 |
| CRP, mg/l | 7·5 (2·0–78·8) | 37·7 (2·0–397·5) | <0·001 |
| Albumin, mg/l | 30 (17–44) | 24 (16–40) | <0·001 |
MELD: model of end-stage liver disease; INR: international normalized ratio; ALT: alanine aminotransferase; CRP: C-reactive protein.